what is glp-1 drug made from Compounded" drugs | Health Communication Research Laboratory 💊GLP-1 Drugs (Anti- #diabetic +

[cited 2024 Nov 10]

Consistency matters most

October 2023: JAMA Research Letter Warns of Possible Ozempic Risks A research letter filed in the Journal of the American Medical Association alleges the risk of adverse gastrointestinal events associated with the use of GLP-1 agonists that are used not only to treat diabetes but also off-label for weight loss

Patients perceive the discontinuation of anti-obesity medication coverage as stigmatizing and unjust, leading to feelings of hopelessness and fear

Similar content being viewed by others Introduction Weight loss can arise in a variety of clinical contexts, including chronic diseases such as anorexia nervosa and inflammatory bowel disease, as well as from active medical interventions like bariatric surgery and pharmacotherapy